REVIVA PHARMACEUTCLS HLDGS I's ticker is RVPHW and the CUSIP is 76152G118. A total of 7 filers reported holding REVIVA PHARMACEUTCLS HLDGS I in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $21,250 | -62.4% | 85,000 | 0.0% | 0.17% | -79.9% |
| Q1 2024 | $56,449 | -52.2% | 85,000 | 0.0% | 0.85% | +36.0% |
| Q4 2023 | $118,150 | -9.7% | 85,000 | 0.0% | 0.62% | +320.9% |
| Q3 2023 | $130,900 | -12.0% | 85,000 | 0.0% | 0.15% | +13.0% |
| Q2 2023 | $148,750 | +78.6% | 85,000 | 0.0% | 0.13% | +104.7% |
| Q1 2023 | $83,300 | -1.0% | 85,000 | 0.0% | 0.06% | -17.9% |
| Q4 2022 | $84,150 | -99.5% | 85,000 | 0.0% | 0.08% | +875.0% |
| Q3 2022 | $16,235,000 | +108133.3% | 85,000 | 0.0% | 0.01% | +14.3% |
| Q2 2022 | $15,000 | -28.6% | 85,000 | 0.0% | 0.01% | -50.0% |
| Q1 2022 | $21,000 | -99.9% | 85,000 | 0.0% | 0.01% | -54.8% |
| Q4 2021 | $29,750,000 | – | 85,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Arena Investors LP | 85,000 | $21,250 | 0.17% |
| Walleye Capital LLC | 33,718 | $9,104 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Walleye Trading LLC | 25,727 | $6,946 | 0.00% |
| UBS Group AG | 4,661 | $1,258 | 0.00% |